A collection of 12 reviews, comprising three reflective pieces and nine research and development agendas, is published as part of a sponsored Supplement on 25 January 2011 in PLoS Medicine. This Collection highlights the outcomes of a series of consultations among more than 250 experts that were undertaken by the Malaria Eradication Research Agenda (malERA) initiative.
The introductory article by Pedro L. Alonso, CRESIB-Hospital Clínic, University of Barcelona, Barcelona, Spain and colleagues, "A Research Agenda to Underpin Malaria Eradication" sets the malERA program in context. The nine research and development agendas define the priority research areas for eight different thematic areas including basic science and enabling technologies; drugs; vaccines; vector control; health systems and operational research; modelling; diagnoses and diagnostics; and monitoring, evaluation and surveillance. An additional paper identifies research priorities that are common to several of the thematic areas.
The Collection includes an analysis from Jose Najera (formerly at the WHO, Geneva) and colleagues, of the last Global Malaria Eradication Programme (1955�) and outlines lessons for future eradication programs. A second analysis by Myron M. Levine, University of Maryland School of Medicine, Baltimore, USA and colleagues, examines the role research has played in eradication or elimination initiatives for smallpox, poliomyelitis, and measles and from this analysis derives nine cross-cutting lessons for malaria eradication.
Pedro L. Alonso comments: "As chair of the malERA Steering Committee, I am delighted to see published this R&D agenda for malaria eradication, after an intense and perhaps unprecedented consultative process that lasted two years and involved more than 250 of the leading scientists in the malaria field and beyond".
Marcel Tanner, Swiss Tropical Institute, Basel, Switzerland (co-chair of the malERA Steering Committee), adds: "I am confident that the definition of this set of key research and development priorities will contribute to paving the way for the ultimate goal of malaria elimination and eradication. Elimination and finally eradication are public health objectives we can not afford not to dream of. The research agenda we publish today shows the strong commitment felt within the research and scientific communities and complements the Global Action Plan for elimination/eradication".
The Malaria Eradication Research Agenda (malERA) initiative aimed to complement existing research agendas that are primarily aimed at reducing the global burden of morbidity and mortality due to malaria (the traditional goal of malaria control) with a set of research and development priorities that identify knowledge gaps and tools needed for worldwide eradication of malaria.
The malERA consultation process was led by a Steering Committee composed of 14 independent scientists (chaired by Pedro L. Alonso), an International Advisory Committee (chaired by Myron M. Levine) that included veterans from eradication and elimination campaigns of both malaria and other diseases, and a Leadership Council comprising Dr. Margaret Chan, Director-General of the World Health Organization, Dr. Tadataka Yamada, President of the Global Health Program of the Bill & Melinda Gates Foundation, Dr. Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases, Dr. Mark Walport, Director of the Wellcome Trust, and Dr. Awa Coll-Seck, Executive Director of the Roll Back Malaria Partnership Board.
The Supplement was produced with support from the Malaria Eradication Research Agenda (malERA) initiative, which was funded by a grant from the Bill & Melinda Gates Foundation. The PLoS Medicine journal editors have sole editorial responsibility for the content of this Collection.
The Supplement will be hosted on a PLoS Medicine Collection page, where all 12 articles can be accessed: www.ploscollections.org/malERA2011
Introductory Article by Pedro Alonso and Colleagues: 'A Research Agenda to Underpin Malaria Eradication'
Funding: malERA received a grant from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: GB declares that he is Chair of MALVAC, Chair USAID Malaria Vaccine Development Program Scientific Consultants Group, a member of the Board of Roll Back Malaria, and a member of the APMEN Advisory Board.
Citation: Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, et al. (2011) A Research Agenda to Underpin Malaria Eradication. PLoS Med 8(1): e1000406.doi:10.1371/journal.pmed.1000406
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000406
PRESS-ONLY PREVIEW OF THE ARTICLE: www.plos.org/press/plme-08-01-malERaintro.pdf
PRESS CONTACTS FOR THE malERA SUPPLEMENT:
Katie Hickling
press@plos.org
Matiana González
matiana.gonzalez@cresib.cat
About PLoS Medicine
PLoS Medicine is an open access, freely available international medical journal. It publishes original research that enhances our understanding of human health and disease, together with commentary and analysis of important global health issues. For more information, visit http://www.plosmedicine.org
About the Public Library of Science
The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org
Journal
PLoS Medicine